In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET is a research paper published in Alzheimer s & Dementia (2020). On theSindex it has a DataRank of 0. It has been cited 302 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute on Aging
Grant: P50AG047270
National Institute on Aging
Grant: K23AG057784
National Institute on Aging
Grant: R01AG052560
National Institute on Aging
Grant: R01AG062276
National Institute on Aging
Grant: RF1AG057553
NIA NIH HHS
Grant: K23 AG057794
NCATS NIH HHS
Grant: UL1 TR000142
NIA NIH HHS
Grant: RF1 AG057784
NIMH NIH HHS
Grant: T32 MH019961
NIA NIH HHS
Grant: P30 AG066508
NCATS NIH HHS
Grant: UL1 TR001863
National Institutes of Health
Dana Foundation
National Center for Advancing Translational Sciences
American Brain Foundation
FWCI
16.20
Citation Percentile
1.0%
Influential Citations
5
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Association of Aβ deposition and regional synaptic density in early Alzheimer’s disease: a PET imaging study with [11C]UCB-J
Additional file 1 of Association of Aβ deposition and regional synaptic density in early Alzheimer’s disease: a PET imaging study with [11C]UCB-J
Additional file 2 of Association of Aβ deposition and regional synaptic density in early Alzheimer’s disease: a PET imaging study with [11C]UCB-J
Additional file 2 of Association of Aβ deposition and regional synaptic density in early Alzheimer’s disease: a PET imaging study with [11C]UCB-J
Additional file 1 of In vivo tau pathology is associated with synaptic loss and altered synaptic function
Additional file 1 of In vivo tau pathology is associated with synaptic loss and altered synaptic function
Additional file 1 of Identifying degenerative effects of repetitive head trauma with neuroimaging: a clinically-oriented review
Additional file 1 of Identifying degenerative effects of repetitive head trauma with neuroimaging: a clinically-oriented review
Additional file 1 of Feasibility of imaging synaptic density in the human spinal cord using [11C]UCB-J PET
Additional file 1 of Feasibility of imaging synaptic density in the human spinal cord using [11C]UCB-J PET
Additional file 2 of Feasibility of imaging synaptic density in the human spinal cord using [11C]UCB-J PET
Additional file 2 of Feasibility of imaging synaptic density in the human spinal cord using [11C]UCB-J PET
Additional file 1 of Synaptic vesicle glycoprotein 2 A in serum is an ideal biomarker for early diagnosis of Alzheimer’s disease
Additional file 1 of Synaptic vesicle glycoprotein 2 A in serum is an ideal biomarker for early diagnosis of Alzheimer’s disease
Additional file 1 of 14-3-3 $$\upzeta /\updelta$$ ζ / δ -reported early synaptic injury in Alzheimer’s disease is independently mediated by sTREM2
Additional file 1 of 14-3-3 $$\upzeta /\updelta$$ ζ / δ -reported early synaptic injury in Alzheimer’s disease is independently mediated by sTREM2
Additional file 1 of A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer’s disease
Additional file 1 of A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer’s disease
Additional file 2 of A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer’s disease
Additional file 2 of A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer’s disease